IPO Premiums
IPO calendar
CLListed

Curis Lifesciences Limited

Bookbuilding IPO · NSE

Price band
₹120 - ₹128
Lot size
1,000 shares
Issue amount
₹27.52 cr
Total subscription
74.47×
Current price₹208.75
Listing price ₹146.1
Watch live price ↗
Opens
7 Nov 2025
Closes
11 Nov 2025
Allotment
12 Nov 2025
Listing
14 Nov 2025

Offer at a glance

Issue overview

Issue size
21,50,000 shares
Face value
₹10 per share
Minimum investment
₹1,20,000
Fresh issue
₹27.52 cr
Offer for sale
₹0 cr
Registrar
Link Intime India Private Limited
Listing exchange
NSE
Maximum investment
₹1,28,000
Issue type
Bookbuilding IPO
Shares before issue
59,34,434
Shares after issue
80,84,434

Lot sizes

CategoryLotsSharesAmount
RETAIL22,000₹2,56,000
sHNI33,000₹3,84,000
bHNI88,000₹10,24,000

Share reservation

Anchor28.37%
QIB18.98%
HNI14.33%
RETAIL33.3%
Market Maker5.02%

Subscription & GMP

Subscription by category

Total subscribed74.47×

Reported 11 Nov 2025

QIB96.17×
NIB115.81×
RETAIL44.28×
HNIs(10L+)143.26×
HNIs(2-10L)60.38×

GMP history

03.5731 Oct: ₹04 Nov: ₹06 Nov: ₹47 Nov: ₹410 Nov: ₹511 Nov: ₹412 Nov: ₹7
31 Oct₹712 Nov

Day-wise demand

7 Nov3.07×
10 Nov5.25×
11 Nov74.47×

Application-wise demand

CategoryReserved applicationsApplied applications
QIB044
NIB05,576
RETAIL35815,853
HNIs(10L +)693,605
HNIs (2-10L)341,971

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs5.24503.49
FIIs0187.28
FIs010.34
Others0305.87
RETAIL9.16405.84
NIB3.94456.59
HNIs 2+1.3178.84
HNIs 10+2.64377.75

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profitIn Crores
0204060Mar-23 · Revenue: 36.42Mar-23 · Profit after tax: 1.88Mar-23Mar-24 · Revenue: 35.87Mar-24 · Profit after tax: 4.87Mar-24Mar-25 · Revenue: 49.65Mar-25 · Profit after tax: 6.11Mar-25Jul-25 · Revenue: 19.51Jul-25 · Profit after tax: 2.87Jul-25
RevenueProfit after tax

Key performance indicators

MetricJul-25Mar-25Mar-24Mar-23
EPS0000
ROE16.2655.25141.512,752.56
ROCE11.6527.8333.5714.83
RONW0000
PRE IPO(PE)012.4400
POST IPO(PE)12.01000

Values and labels as reported in the issue data.

Peer comparison

CompanyP/E(X)CMP* (₹)Face value (₹)NAV/Share (₹)RONW(%)EPS (Basic) (₹)
Curis Lifesciences Limited00027.3437.6210.29
Sotac Pharmaceuticals Limited18.300047.999.004.32
Lincoln Pharmaceuticals Limited12.2100335.3412.2741.11

Company information

Company profile

Curis Lifesciences Limited, founded in 2010, is a pharmaceutical company engaged in developing, manufacturing, and distributing a wide range of medicines. It produces pharmaceutical products for both domestic and global markets through loan license, contract manufacturing, and its own brand marketing. The company serves over 100 corporate clients under contract manufacturing and two clients for its own brands in Yemen and Kenya. Its product range includes tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments. The company operates a modern manufacturing facility in Sanand, Gujarat, maintaining strict quality standards, and as of July 31, 2025, it employs 95 permanent staff.

Strengths

  • Experienced Leadership and Skilled Management: Promoters with 13–15 years of experience in the pharmaceutical sector and medical expertise lead the company, ensuring informed strategic decisions, operational efficiency, and sustained client trust.
  • Broad and Diverse Product Range: Offers an extensive portfolio including tablets, capsules, oral liquids, external applications, and sterile ophthalmic ointments, supported by valid manufacturing licenses (G/25/2225 and G/28/1632).
  • WHO-GMP Certified Facility with Global Reach: The Sanand, Gujarat-based manufacturing unit is WHO-GMP certified, strategically located for logistics and skilled workforce access, and holds international product registrations in markets such as Yemen, Kenya, the Philippines, and Nigeria.

Risk factors

  • Operational Concentration Risk: Heavy reliance on a single manufacturing facility in Sanand, Ahmedabad (Gujarat) exposes the company to regional, environmental, and regulatory risks that could disrupt operations and impact financial performance.
  • Regulatory and Approval Challenges: As part of a highly regulated sector, delays or lapses in obtaining or renewing statutory licenses, certifications, or product approvals may hinder business continuity and affect profitability.
  • Debt Servicing and Compliance Risk: Previous delays in loan repayments pose potential reputational and financial risks; continued focus on disciplined financial management is crucial to maintain lender confidence and credit health.

Promoters

Mr. Dharmesh Dashrathbhai Patel

Mr. Siddhant Jayantibhai Pawasia

Mr. Piyush Gordhanbhai Antala

Mr. Jaimik Mansukhbhai Patel

Registrar & documents

Lead manager

Finaax Capital Advisors Private Limited

Registered office

PF-23, GIDC Sanand - II, Industrial Estate, Sanand Ahmedabad, Gujarat, 382110

+91 99045 22543

[email protected]Company website ↗

Frequently Asked Questions

What is Curis Lifesciences IPO GMP today?

As of today, Curis Lifesciences IPO Grey Market Premium (GMP) is reported at +₹7 per share. Based on the upper price band of ₹128, the estimated listing price is ₹135 (+5.5% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Curis Lifesciences IPO?

The minimum bid lot size for Curis Lifesciences IPO is 1,000 shares. At the cut-off price of ₹128 per share, retail investors need a minimum application amount of ₹1,28,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Curis Lifesciences IPO allotment status be announced?

The allotment status for Curis Lifesciences IPO is scheduled to be finalized on 12 Nov 2025. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Link Intime India Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Curis Lifesciences IPO allotment status online by PAN?

To check Curis Lifesciences IPO allotment status: 1) Visit the registrar portal (Link Intime India Private Limited) or the BSE IPO allotment page. 2) Select 'Curis Lifesciences Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Curis Lifesciences IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums